- Home
- ONCO vs APDN Comparison
ONCO vs APDN Comparison
Compare ONCO & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- APDN
- Stock Information
- Founded
- ONCO 2018
- APDN 1983
- Country
- ONCO United States
- APDN United States
- Employees
- ONCO N/A
- APDN N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- ONCO Health Care
- APDN Consumer Discretionary
- Exchange
- ONCO Nasdaq
- APDN Nasdaq
- Market Cap
- ONCO 1.8M
- APDN 1.7M
- IPO Year
- ONCO 2022
- APDN N/A
- Fundamental
- Price
- ONCO $3.00
- APDN $2.87
- Analyst Decision
- ONCO
- APDN
- Analyst Count
- ONCO 0
- APDN 0
- Target Price
- ONCO N/A
- APDN N/A
- AVG Volume (30 Days)
- ONCO 46.7K
- APDN 251.6K
- Earning Date
- ONCO 08-14-2025
- APDN 08-26-2025
- Dividend Yield
- ONCO N/A
- APDN N/A
- EPS Growth
- ONCO N/A
- APDN N/A
- EPS
- ONCO N/A
- APDN 211.51
- Revenue
- ONCO $1,326,959.00
- APDN $3,743,063.00
- Revenue This Year
- ONCO N/A
- APDN $57.08
- Revenue Next Year
- ONCO N/A
- APDN $40.00
- P/E Ratio
- ONCO N/A
- APDN $0.01
- Revenue Growth
- ONCO N/A
- APDN 55.60
- 52 Week Low
- ONCO $2.61
- APDN $2.13
- 52 Week High
- ONCO $552.50
- APDN $1,064.85
- Technical
- Relative Strength Index (RSI)
- ONCO 47.80
- APDN 40.01
- Support Level
- ONCO $3.00
- APDN $2.40
- Resistance Level
- ONCO $3.32
- APDN $2.97
- Average True Range (ATR)
- ONCO 0.16
- APDN 0.31
- MACD
- ONCO 0.06
- APDN 0.09
- Stochastic Oscillator
- ONCO 52.94
- APDN 43.53
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.